Clinical trial of mehamudgar vati on diabetes

A comparative clinical study of mehamudgar vati and triphaladi vati along with oha in the management of prameha with special reference to type ? diabetes. - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/078426

Enrollment

220

Registered

2024-12-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs and symptoms of Prameha as mentioned in Ayurvedic texts Diagnosed patient with (BSF between 125-200 , PPBS 200-280 & HBA1C 6.4 to 7.5% according to American Association of Diabetes) Age of patients - 30-60 year ? Gender - males and females

Exclusion criteria

Exclusion criteria: Patient having Type 1 DM Patient having Type 2 DM below age 30 and above age 60 Gestational diabetes Pregnant & lactating mothers Patients having Acute Complications like Coronary Heart Disease, Acute Infective hepatitis, alcoh

Design outcomes

Primary

Measure	Time frame
sugar level (fasting, postprandial) will be monitor every after 15 days. HbA1c will be checked at first day visit and after 120 daysTimepoint: for 4 months	—

Secondary

Measure	Time frame
clinical manifestation of diabetes (prameha) will be monitor after every 1 month. 1)tiredness ( dourbalya) 2) frequent micturition (prabhut mutrata) 3) excessive sweat (sweda-adhikya) 4) increased thirst(pipasa-adhikya) 5) increased appetite(kshuda-adhikya) 6) tingling sensation in foot, hand (kar-pad daha )Timepoint: for 4 months every after one month	—

Countries

India

Contacts

Public ContactDr Mangesh Malpe

Shri Saptashrungi Ayurved College

somdattak85@gmail.com9975564288

Outcome results